REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $7,785,000 | -26.9% | 450,000 | -25.0% | 0.41% | -0.5% |
| Q1 2014 | $10,644,000 | -3.1% | 600,000 | 0.0% | 0.41% | -12.3% |
| Q4 2013 | $10,980,000 | +17.1% | 600,000 | +71.4% | 0.47% | 0.0% |
| Q3 2013 | $9,380,000 | -10.0% | 350,000 | -38.1% | 0.47% | -19.4% |
| Q2 2013 | $10,424,000 | – | 565,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
| RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
| SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
| CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
| Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
| Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
| Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |